BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12108031)

  • 1. [The immunohistochemical detection of steroid hormone receptors in breast cancer: open problems and new perspectives].
    Barbareschi M; Doglioni C
    Pathologica; 2002 Jun; 94(3):115-20. PubMed ID: 12108031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology].
    Balaton AL; Coindre JM; Collin F; Ettore F; Fiche M; Jacquemier J; Le Doussal V; Mandard AM; Mathieu MC; Migeon C; Simony-Lafontaine J; Treilleux I; Verriele V; Vilain MO; Zafrani B
    Ann Pathol; 1996; 16(2):144-8. PubMed ID: 8767687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendations for the immunohistochemistry of the hormonal receptors on paraffin sections in breast cancer. Update 1999. Group for Evaluation of Prognostic Factors using Immunohistochemistry in Breast Cancer (GEFPICS-FNCLCC)].
    Ann Pathol; 1999 Sep; 19(4):336-43. PubMed ID: 10544774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical markers as predictive tools for breast cancer.
    Walker RA
    J Clin Pathol; 2008 Jun; 61(6):689-96. PubMed ID: 18037665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen and progesterone receptor status of individual foci in multifocal invasive ductal breast cancer.
    Garimella V; Long ED; O'Kane SL; Drew PJ; Cawkwell L
    Acta Oncol; 2007; 46(2):204-7. PubMed ID: 17453370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of computer-assisted image analysis for the detection of immunohistochemical receptor status in breast cancer. Immunohistochemical densitometry receptor analysis--IRDA].
    Mink D; Bonkhoff H; Herth G; Schmidt W
    Geburtshilfe Frauenheilkd; 1992 Oct; 52(10):617-23. PubMed ID: 1294438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid receptor assays: an Italian quality assessment program.
    Piffanelli A; Giovannini G; Pelizzola D; De Bortoli M; Catozzi L; Giganti M
    Ann Ist Super Sanita; 1991; 27(3):523-9. PubMed ID: 1809075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.
    Colleoni M; Viale G; Zahrieh D; Pruneri G; Gentilini O; Veronesi P; Gelber RD; Curigliano G; Torrisi R; Luini A; Intra M; Galimberti V; Renne G; Nolè F; Peruzzotti G; Goldhirsch A
    Clin Cancer Res; 2004 Oct; 10(19):6622-8. PubMed ID: 15475452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thermolabile characteristics of steroid hormone receptors in breast cancer].
    Merkle E; Bähr I; Tulusan AH; Lang N
    Geburtshilfe Frauenheilkd; 1991 Mar; 51(3):182-5. PubMed ID: 2055391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical detection of estrogen and progesterone receptors in breast cancer using monoclonal antibodies: comparison with biochemical receptor analysis].
    Scharl A; Vierbuchen M; Würz H
    Pathologe; 1989 Jan; 10(1):31-8. PubMed ID: 2646630
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of immunohistochemical staining for oestrogen receptor, progesterone receptor and HER-2 in breast core biopsies and subsequent excisions.
    Wood B; Junckerstorff R; Sterrett G; Frost F; Harvey J; Robbins P
    Pathology; 2007 Aug; 39(4):391-5. PubMed ID: 17676479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer.
    Sharangpani GM; Joshi AS; Porter K; Deshpande AS; Keyhani S; Naik GA; Gholap AS; Barsky SH
    J Microsc; 2007 Jun; 226(Pt 3):244-55. PubMed ID: 17535263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical thoracoscopy: hormone receptor content in pleural metastases due to breast cancer.
    Schwarz C; Lübbert H; Rahn W; Schönfeld N; Serke M; Loddenkemper R
    Eur Respir J; 2004 Nov; 24(5):728-30. PubMed ID: 15516663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.
    Brouckaert O; Pintens S; Van Belle V; Van Huffel S; Camerlynck E; Amant F; Leunen K; Smeets A; Berteloot P; Van Limbergen E; Decock J; Hendrickx W; Weltens C; Van den Bogaert W; Vanden Bempt I; Drijkoningen M; Paridaens R; Wildiers H; Vergote I; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2009 May; 115(2):349-58. PubMed ID: 18629635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A histochemical technique for evaluation of progesterone receptors in breast cancer.
    Pertschuk LP; Tobin EH; Gaetjens E; Degenshein GA; Autuoro LM; Brigati DJ; Bloom ND; Carter AC; Rainford EA
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):635-8. PubMed ID: 461981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer.
    Mann GB; Fahey VD; Feleppa F; Buchanan MR
    J Clin Oncol; 2005 Aug; 23(22):5148-54. PubMed ID: 16051956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.
    Honma N; Horii R; Iwase T; Saji S; Younes M; Takubo K; Matsuura M; Ito Y; Akiyama F; Sakamoto G
    J Clin Oncol; 2008 Aug; 26(22):3727-34. PubMed ID: 18669459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome.
    Francis G; Beadle G; Thomas S; Mengersen K; Stein S
    Pathology; 2006 Oct; 38(5):391-8. PubMed ID: 17008275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.